Veterinary Medicines

GLETVAX 6 συνδυασμένο εμβόλιο χοίρου για την πρόληψη της κολοβακτηριδιάσεων και της νεκρωτικής εντερίτιδας των χοίριδίων

Authorised
  • Escherichia coli, serotype O149:K88 (fimbrial adhesin F4), Inactivated
  • Escherichia coli, strain O8:K87, K88, fimbrial adhesin F4, Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
  • Clostridium perfringens, type B, C and D, beta toxoid
Download as PDF

Product identification

Medicine name:
GLETVAX 6 συνδυασμένο εμβόλιο χοίρου για την πρόληψη της κολοβακτηριδιάσεων και της νεκρωτικής εντερίτιδας των χοίριδίων
Active substance:
  • Escherichia coli, serotype O149:K88 (fimbrial adhesin F4), Inactivated
  • Escherichia coli, strain O8:K87, K88, fimbrial adhesin F4, Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
  • Clostridium perfringens, type B, C and D, beta toxoid
Target species:
  • Pig (piglet)
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Escherichia coli, serotype O149:K88 (fimbrial adhesin F4), Inactivated
    15.50
    log2 antibody unit(s)
    /
    5.00
    millilitre(s)
  • Escherichia coli, strain O8:K87, K88, fimbrial adhesin F4, Inactivated
    14.60
    log2 antibody unit(s)
    /
    5.00
    millilitre(s)
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
    12.20
    log2 antibody unit(s)
    /
    5.00
    millilitre(s)
  • Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
    13.10
    log2 antibody unit(s)
    /
    5.00
    millilitre(s)
  • Clostridium perfringens, type B, C and D, beta toxoid
    300.00
    international unit(s)
    /
    5.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pig (piglet)
  • Intramuscular use
    • Pig (piglet)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB08
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Ministry Of Agriculture Rural Development And Environment
Authorisation number:
  • 19170
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 11/07/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."